The highly anticipated 23rd Annual Conference on Biological Products (CBioPC) will be held at the Guangzhou International Convention and Exhibition Center from May 16th to May 18th, 2024.
As one of the most influential academic events in China's biopharmaceutical field, this year's conference brings together industry elites and sets up a main venue around cutting-edge biopharmaceutical technologies. It also features multiple current hot topics, including vaccine research and quality, immune cells, stem cells and gene therapy, recombinant therapeutic biological products, innovative biological products, and invites the most authoritative experts in the biopharmaceutical field to give academic presentations and exchange ideas. During these four days, biotechnology elites from all over the country gathered together to explore the forefront of the industry and share innovative achievements.
Inner Mongolia AoPusai, as a raw material supplier in the field of life and health, has always been committed to becoming a world-class national brand, serving customers with advanced technology and high-quality products. It actively participated in this industry event and showcased AoPusai fetal bovine serum and Jinyuankang human vaccine specific serum series products.
The attendees stopped at our booth one after another, and the AoPusai friends showed great enthusiasm, carefully answering questions and clarifying doubts for the teachers. Opsey's star products, fetal bovine serum 1101 and 1105, became the focus of attention on site, and with their outstanding performance advantages and stability, they have gained recognition and approval from industry professionals.
During the conference, the founders and experts of Opsey had multiple exciting academic exchanges with the attendees. They shared the company's years of technological accumulation and successful experience around core issues such as product traceability, quality control, research and development, and production. At the same time, they actively listened to the voices of other enterprises and experts, and jointly explored the future development trends and challenges of the industry.
With the gentle breeze of early summer, we witnessed the successful conclusion of the 23rd China Biological Products Conference in Guangzhou.
Let's join hands and move forward together
Together, we will write a new chapter in the biopharmaceutical industry!
Looking forward to meeting again next year!
Inner Mongolia AoPusai Biotechnology Co., Ltd. is a wholly-owned subsidiary of Inner Mongolia Jinyuankang Bioengineering Co., Ltd. Since its establishment, it has always adhered to the concept of high-quality domestic products and surpassing imports, providing customers with more professional products and more systematic services.
The company has a sound quality assurance system and a professional quality control team. Quality management is strictly carried out in accordance with the requirements of the "National Bovine Serum Production Enterprise Standard Inspection Manual". Adopting a large capacity mixing process, the single batch production capacity can reach 7600 bottles, with large batch sizes and small inter batch differences, which can effectively reduce customer testing frequency.
As a raw material supplier in the field of life and health, we are committed to becoming a world-class national brand, serving our customers with advanced technology and high-quality products.
Scan to follow